The Women in Industry Awards recognise and reward the achievements of women working within the mining, engineering, manufacturing, process control industries and commercial road transport industries.
“I am delighted to offer our sincere congratulations to Lisa for this wonderful recognition. Throughout her career with CSL, Lisa has continually demonstrated valued leadership, innovation and commitment to our business and public health. It is wonderful through the Women in Industry Awards to be able to share and celebrate what we have always known about Lisa with the wider manufacturing community” said Gordon Naylor, President of Seqirus.
“The foundation of a successful business is its people and at Seqirus we are committed to empowering our people to achieve their leadership aspirations by creating a work environment that enables and supports our team to be the best they can be,” Mr Naylor said.
Lisa joined CSL Limited, 23 years ago as a medical sales representative in the commercial team; from there she has worked across a number of areas of the biologic business including brand manager for vaccines, planning, supply chain and now manufacturing.
As Manufacturing Director for Seqirus’ Products of National Significance (PNS), Lisa leads a team of 30 employees based across three operating sites in Victoria producing unique lifesaving products for the benefit of Australian public health.
The diverse PNS portfolio of products includes Q-Fever skin test and vaccine, along with 11 antivenoms for Australia’s most venomous snakes, spiders and marine animals.
About the Awards
The Women in Industry Awards recognise and reward the achievements of women working within the mining, engineering, manufacturing, process control industries and commercial road transport industries. The Women in Industry Manufacturing Excellence Award recognises an individual who has thought ‘outside the box’ to implement an outstanding personal contribution to their manufacturing business and the wider manufacturing community. More information about the Women in Industry Awards > .
Download This Release
Seqirus, a CSL company is a leading provider of essential vaccines, pharmaceutical products and diagnostic reagents. We have served Australia’s healthcare needs for over a century and today we operate Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine. Seqirus produces a range of unique medicines in the National Interest, and also in-licences a broad range of paediatric and adult vaccines and specialty pharmaceutical products.
With the extensive research and production expertise and manufacturing plants in US, UK, and Australia, Seqirus is driven by the promise it shares with parent company, CSL Limited (ASX:CSL), to provide medicines that help to protect and save lives.